# Remifentanil Monotherapy vs. Remifentanil-Nicardipine for Controlled Hypotension in Otolaryngological Surgery

> **NCT07659496** · NA · NOT_YET_RECRUITING · sponsor: **Dicle University** · enrollment: 60 (estimated)

## Conditions studied

- Otolaryngological Surgery
- Anesthesia

## Interventions

- **DRUG:** Remifentanil / Nicardipine
- **DRUG:** Remifentanil

## Key facts

- **NCT ID:** NCT07659496
- **Lead sponsor:** Dicle University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-30
- **Primary completion:** 2026-08-15
- **Final completion:** 2026-08-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07659496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07659496, "Remifentanil Monotherapy vs. Remifentanil-Nicardipine for Controlled Hypotension in Otolaryngological Surgery". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07659496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*